European Phase III Study of APD421 in PONV

Study of APD421 With and Without Ondansetron

NCT03583489 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

NCT06543966 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting

NCT00717054 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

NCT06932107 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery

NCT06887621 ·Status: RECRUITING ·Phase: PHASE2

Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric Patients

NCT00956215 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)

NCT01732458 ·Status: COMPLETED ·Phase: PHASE2

Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients

NCT07248280 ·Status: RECRUITING ·Phase: PHASE3

Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting

NCT01474915 ·Status: COMPLETED ·Phase: PHASE4

2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)

NCT00090246 ·Status: COMPLETED ·Phase: PHASE3

2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)

NCT00090155 ·Status: COMPLETED ·Phase: PHASE3

A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting

NCT00108095 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012)

NCT00990821 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.

NCT00733551 ·Status: COMPLETED ·Phase: PHASE1

A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED)

NCT00539721 ·Status: COMPLETED ·Phase: PHASE2

A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148)

NCT00819039 ·Status: COMPLETED ·Phase: PHASE1

A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)

NCT00231777 ·Status: COMPLETED ·Phase: PHASE3

Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide

NCT06740812 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial

NCT01149369 ·Status: COMPLETED ·Phase: PHASE2

Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery

NCT06488001 ·Status: RECRUITING ·Phase: PHASE2

Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting

NCT02143531 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Adding EMEND to PONV/PDNV Treatment Regimen

NCT01186029 ·Status: WITHDRAWN ·Phase: NA

Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting

NCT00659737 ·Status: COMPLETED ·Phase: NA

Postoperative Vomiting in Children: Comparison Tri - Versus bi -Prophylaxis

NCT01739985 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients

NCT01395901 ·Status: COMPLETED ·Phase: PHASE3